McCarthy Cornelius P. III sold $465K of MEDP
McCarthy Cornelius P. III sold 795 shares of Medpace Holdings, Inc. (MEDP) at $585.07 ($0.47M total) on 2026-08-07.
How this was made
The 30-second read
Why it matters
The newest information is the specific insider sale size, price, and post-transaction holdings. It does not include any new corporate guidance, contracts, or regulatory/clinical updates.
Market read
Traders may monitor insider activity as a sentiment input, but this filing alone is unlikely to drive a major repricing without additional fundamental catalysts.
What to watch
The article provides only the sale details, not context such as prior holdings, compensation timing, or whether other insiders sold/bought around the same period.
Background
The article is a SEC Form 4 insider transaction disclosure for Medpace Holdings, Inc.
Ticker impact
Medpace director McCarthy Cornelius P. III sold 795 shares in an open-market transaction for about $465K, per a newly filed Form 4.
Low likelihood of a sustained price move; any reaction is likely limited to intraday sentiment around the filing.
The filing is a routine Form 4 insider sale with no 10b5-1 plan stated and no accompanying operational or guidance change disclosed in the text.
Market effects
No sector read-through is provided; this appears company-specific and routine.
None indicated.
None indicated.
Counterpoint
Insider sales can be planned for diversification or tax needs; without a stated 10b5-1 plan, the sale still may not signal negative fundamentals.
Key entities
- issuerMedpace Holdings, Inc.
Subject of the Form 4 insider sale disclosure (MEDP).
- insiderMcCarthy Cornelius P. III
Director who sold 795 shares in an open-market transaction.
